DeMar DeRozan: Everything you need to know

DeMar DeRozan

#10 SF

Sacramento Kings

Status

OUT - Hamstring - Strain Expected Return: 2026-10-01

STATS

Career Averages

PTS

REB

AST

BLK

STL

23.0

4.5

4.8

0.3

1.0

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	77	77	31.2	18.4	2.9	4.1	0.3	1.0	1.2	2	0	0.6	1.9	32.0%	5.9	11.1	52.7%	6.5	13.1	49.7%	4.9	5.6	86.8%	0.5	2.5	1.9	3.3	-588	59.4%
2024-25	77	77	35.9	22.2	3.9	4.4	0.4	0.8	1.4	3	0	1.1	3.3	32.8%	7.0	13.7	51.3%	8.1	17.0	47.7%	4.9	5.7	85.7%	0.6	3.2	1.9	3.3	+110	56.9%
2023-24	79	79	37.8	24.0	4.3	5.3	0.6	1.1	1.7	7	0	0.9	2.8	33.3%	7.3	14.3	50.9%	8.2	17.2	48.0%	6.6	7.7	85.3%	0.5	3.8	2.0	3.1	-62	58.4%
2022-23	74	74	36.2	24.5	4.6	5.1	0.5	1.1	2.1	6	0	0.6	1.9	32.4%	8.3	15.7	52.6%	8.9	17.6	50.4%	6.2	7.1	87.2%	0.5	4.2	2.5	2.5	+67	59.2%
2021-22	76	76	36.1	27.9	5.2	4.9	0.3	0.9	2.4	6	0	0.7	1.9	35.2%	9.5	18.3	52.0%	10.2	20.2	50.4%	6.8	7.8	87.7%	0.7	4.4	2.3	2.1	+77	59.0%
2020-21	61	61	33.7	21.6	4.2	6.9	0.2	0.9	2.0	13	0	0.3	1.2	25.7%	7.1	13.9	51.5%	7.5	15.1	49.5%	6.3	7.2	88.0%	0.7	3.6	2.1	3.5	-105	59.1%
2019-20	68	68	34.1	22.1	5.5	5.6	0.3	1.0	2.4	7	0	0.1	0.5	25.7%	8.1	14.9	54.0%	8.2	15.4	53.1%	5.6	6.6	84.5%	0.6	4.9	2.6	2.3	-118	60.3%
2018-19	77	77	34.9	21.2	6.0	6.2	0.5	1.1	2.6	12	1	0.1	0.6	15.6%	8.1	16.5	49.2%	8.2	17.1	48.1%	4.8	5.7	83.0%	0.7	5.3	2.3	2.4	+10	54.2%
2017-18	80	80	33.9	23.0	3.9	5.2	0.3	1.1	2.2	0	0	1.1	3.6	31.0%	7.0	14.1	49.4%	8.1	17.7	45.6%	5.8	7.0	82.5%	0.7	3.2	1.9	2.4	+440	55.5%
2016-17	74	74	36.4	27.3	5.2	3.9	0.2	1.1	2.4	0	0	0.4	1.7	26.6%	9.3	19.2	48.4%	9.7	20.9	46.7%	7.4	8.7	84.2%	0.9	4.3	1.8	1.6	+0	55.2%
2015-16	78	78	35.9	23.5	4.5	4.0	0.3	1.0	2.2	0	0	0.6	1.8	33.8%	7.3	15.9	45.8%	7.9	17.7	44.6%	7.1	8.4	85.0%	0.8	3.7	2.1	1.8	+0	55.0%
2014-15	60	60	35.0	20.1	4.6	3.5	0.2	1.2	2.3	0	0	0.4	1.5	28.4%	6.4	15.0	42.6%	6.8	16.5	41.3%	6.0	7.2	83.2%	0.7	3.9	2.0	1.5	+0	51.0%
2013-14	79	79	38.2	22.7	4.3	4.0	0.4	1.1	2.2	0	0	0.8	2.7	30.5%	6.8	15.2	45.1%	7.6	17.8	42.9%	6.6	8.0	82.4%	0.6	3.7	2.5	1.8	+0	53.2%
Career	960	960	35.4	23.0	4.5	4.8	0.3	1.0	2.1	56	1	0.6	2.0	31.1%	7.5	15.2	49.6%	8.2	17.2	47.5%	6.1	7.1	85.0%	0.7	3.9	2.2	2.3	-169	56.6%

Career Averages

PTS

REB

AST

BLK

STL

21.8

4.7

3.7

0.2

1.1

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2021-22	5	5	40.6	20.8	5.4	4.8	0.4	1.8	2.2	0	0.0	1.8	0.0%	7.8	17.2	45.3%	7.8	19.0	41.1%	5.2	6.0	86.7%	0.2	5.2	2.4	2.2	-65	48.1%
2018-19	7	7	35.9	22.0	6.7	4.6	0.1	1.1	1.7	1	0.0	0.1	0.0%	8.3	16.9	49.2%	8.3	17.0	48.7%	5.4	6.3	86.4%	1.4	5.3	2.3	2.7	-33	55.7%
2017-18	10	10	35.4	22.7	3.6	4.0	0.6	0.5	2.3	0	1.0	3.5	28.6%	7.7	16.4	47.0%	8.7	19.9	43.7%	4.3	5.3	81.1%	0.6	3.0	2.4	1.7	-65	51.1%
2016-17	10	10	37.3	22.4	4.9	3.4	0.0	1.4	2.5	0	0.1	1.5	6.7%	7.5	16.0	46.9%	7.6	17.5	43.4%	7.1	8.0	88.8%	0.4	4.5	2.6	1.4	+0	53.3%
2015-16	20	20	37.3	20.9	4.2	2.7	0.2	1.1	2.3	0	0.2	1.3	15.4%	7.7	18.6	41.1%	7.9	19.9	39.4%	5.0	6.2	81.3%	0.7	3.5	2.6	1.2	+0	46.2%
2014-15	4	4	39.8	20.3	6.3	5.8	0.0	1.5	2.5	0	0.8	2.0	37.5%	7.3	18.0	40.3%	8.0	20.0	40.0%	3.5	4.3	82.4%	1.3	5.0	3.0	2.3	+0	46.3%
2013-14	7	7	40.3	23.9	4.1	3.6	0.3	1.1	2.6	0	0.9	2.6	33.3%	5.6	14.1	39.4%	6.4	16.7	38.5%	10.1	11.3	89.9%	0.4	3.7	3.3	1.4	+0	55.0%
Career	63	63	37.6	21.8	4.7	3.7	0.2	1.1	2.3	1	0.4	1.8	21.4%	7.5	17.0	43.9%	7.8	18.8	41.8%	5.8	6.8	85.2%	0.7	4.0	2.6	1.6	-163	50.2%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/15	LAC	L 109-91	31	9	3	2	0	0	1	3	1	33.3%	4	1	25.0%	7	2	28.6%	5	4	80.0%	0	3	2.0	-18	3	7	48.9%
10/10	POR	L 124-123	22	10	1	0	0	0	1	1	0	0.0%	4	4	100.0%	5	4	80.0%	2	2	100.0%	0	1	0.0	+3	0	12	85.0%
10/8	TOR	L 130-122	23	6	6	4	1	0	1	2	1	50.0%	4	1	25.0%	6	2	33.3%	1	1	100.0%	0	6	4.0	-8	1	11	46.6%
Preseason Totals			25.9	8.3	3.3	2.0	0.3	0.0	1.0	2.0	0.7	33.3%	4.0	2.0	50.0%	6.0	2.7	44.4%	2.7	2.3	87.5%	0.0	3.3	2.0	-23	1.3	11.7	58.1%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/5	LAC	L 138-109	10	9	0	0	1	0	1	1	1	100.0%	4	3	75.0%	5	4	80.0%	0	0	0.0%	0	0	0.0	+2	0	8	90.0%
4/3	NOP	W 117-113	23	14	2	5	0	2	0	0	0	0.0%	11	7	63.6%	11	7	63.6%	0	0	0.0%	0	2	0.0	+1	2	19	63.6%
4/1	TOR	W 123-115	34	28	1	4	0	0	1	4	2	50.0%	14	5	35.7%	18	7	38.9%	12	12	100.0%	1	0	4.0	+2	2	25	60.1%
3/28	ATL	L 123-113	30	22	4	3	0	0	3	2	1	50.0%	16	8	50.0%	18	9	50.0%	3	3	100.0%	2	2	1.0	-7	2	15	56.9%
3/26	ORL	L 121-117	38	33	6	11	0	0	0	1	0	0.0%	23	12	52.2%	24	12	50.0%	10	9	90.0%	0	6	0.0	-5	3	41	58.1%
3/24	CHA	L 134-90	28	7	4	5	0	0	2	2	0	0.0%	8	3	37.5%	10	3	30.0%	3	1	33.3%	1	3	2.5	-29	0	7	30.9%
3/22	BKN	W 126-122	31	10	0	8	1	0	2	2	0	0.0%	5	3	60.0%	7	3	42.9%	4	4	100.0%	0	0	4.0	+0	2	13	57.1%
3/19	PHI	L 139-118	23	13	3	5	0	0	2	1	0	0.0%	9	6	66.7%	10	6	60.0%	2	1	50.0%	1	2	2.5	-26	2	13	59.7%
3/17	SAS	L 132-104	16	2	1	1	0	0	0	0	0	0.0%	4	1	25.0%	4	1	25.0%	0	0	0.0%	0	1	0.0	-30	2	1	25.0%
3/15	UTA	W 116-111	38	41	4	11	0	3	5	3	1	33.3%	18	10	55.6%	21	11	52.4%	21	18	85.7%	1	3	2.2	+16	0	51	67.8%
3/14	LAC	W 118-109	36	27	0	7	0	1	4	1	0	0.0%	13	11	84.6%	14	11	78.6%	5	5	100.0%	0	0	1.8	+9	4	29	83.3%
3/11	CHA	L 117-109	40	39	4	6	1	2	4	1	0	0.0%	21	17	81.0%	22	17	77.3%	5	5	100.0%	0	4	1.5	+3	3	43	80.6%
3/10	IND	W 114-109	23	12	3	1	2	1	2	0	0	0.0%	13	4	30.8%	13	4	30.8%	4	4	100.0%	1	2	0.5	-9	2	10	40.7%
3/5	NOP	L 133-123	27	15	2	2	0	1	1	2	0	0.0%	14	6	42.9%	16	6	37.5%	5	3	60.0%	0	2	2.0	+0	1	8	41.2%
3/3	PHX	L 114-103	33	17	2	1	0	0	1	2	0	0.0%	13	5	38.5%	15	5	33.3%	9	7	77.8%	0	2	1.0	-14	1	10	44.8%
3/1	LAL	L 128-104	22	9	4	8	0	0	2	2	1	50.0%	3	2	66.7%	5	3	60.0%	2	2	100.0%	0	4	4.0	-9	1	18	76.5%
2/26	DAL	W 130-121	25	7	2	5	1	0	0	0	0	0.0%	3	1	33.3%	3	1	33.3%	6	5	83.3%	0	2	0.0	+20	1	13	62.1%
2/25	HOU	L 128-97	23	15	1	7	0	1	1	0	0	0.0%	7	4	57.1%	7	4	57.1%	8	7	87.5%	0	1	7.0	-9	2	24	71.3%
2/23	MEM	W 123-114	28	19	2	4	2	2	0	0	0	0.0%	9	7	77.8%	9	7	77.8%	6	5	83.3%	0	2	0.0	+1	2	26	81.6%
2/21	SAS	L 139-122	34	20	1	5	1	2	2	1	0	0.0%	12	5	41.7%	13	5	38.5%	10	10	100.0%	0	1	2.5	-31	2	20	57.5%
2/19	ORL	L 131-94	19	13	3	6	0	0	0	0	0	0.0%	11	3	27.3%	11	3	27.3%	8	7	87.5%	0	3	0.0	-8	1	15	44.8%
2/11	UTA	L 121-93	29	20	3	1	0	0	0	5	1	20.0%	14	6	42.9%	19	7	36.8%	5	5	100.0%	2	1	0.0	-21	1	15	47.2%
2/9	NOP	L 120-94	19	8	1	1	0	0	1	2	0	0.0%	9	3	33.3%	11	3	27.3%	3	2	66.7%	0	1	1.0	-7	2	1	32.5%
2/7	CLE	L 132-126	29	13	2	3	1	0	0	4	2	50.0%	12	2	16.7%	16	4	25.0%	3	3	100.0%	0	2	0.0	-8	1	5	37.5%
2/6	LAC	L 114-111	20	5	5	1	1	2	1	0	0	0.0%	3	1	33.3%	3	1	33.3%	4	3	75.0%	1	4	1.0	-4	1	12	52.5%
2/4	MEM	L 129-125	27	20	3	5	0	0	1	3	1	33.3%	7	5	71.4%	10	6	60.0%	9	7	77.8%	1	2	5.0	-4	1	25	71.6%
2/1	WAS	L 116-112	32	32	2	5	1	0	3	1	1	100.0%	15	9	60.0%	16	10	62.5%	12	11	91.7%	0	2	1.7	-14	1	38	75.2%
1/30	BOS	L 112-93	18	6	1	2	0	0	0	2	0	0.0%	8	2	25.0%	10	2	20.0%	3	2	66.7%	0	1	0.0	-11	2	0	26.5%
1/29	PHI	L 113-111	37	25	4	8	0	0	1	1	1	100.0%	14	8	57.1%	15	9	60.0%	8	6	75.0%	0	4	8.0	+2	2	32	67.5%
1/27	NYK	L 103-87	38	34	5	0	0	0	2	7	1	14.3%	19	12	63.2%	26	13	50.0%	8	7	87.5%	0	5	0.0	-17	3	27	57.6%
1/25	DET	L 139-116	18	16	0	4	0	0	2	1	0	0.0%	11	6	54.5%	12	6	50.0%	6	4	66.7%	0	0	2.0	-9	3	10	54.6%
1/23	CLE	L 123-118	30	20	4	3	0	0	2	1	0	0.0%	11	6	54.5%	12	6	50.0%	9	8	88.9%	0	4	1.5	-24	3	20	62.7%
1/21	TOR	L 122-109	33	9	1	2	0	1	0	1	0	0.0%	7	3	42.9%	8	3	37.5%	5	3	60.0%	1	0	0.0	-23	0	8	44.1%
1/20	MIA	L 130-117	34	23	4	5	0	0	2	2	1	50.0%	10	5	50.0%	12	6	50.0%	10	10	100.0%	0	4	2.5	-19	3	25	70.1%
1/18	POR	L 117-110	34	14	2	7	1	2	3	1	0	0.0%	10	6	60.0%	11	6	54.5%	3	2	66.7%	1	1	2.3	-14	4	16	56.8%
1/16	WAS	W 128-115	32	17	2	4	0	1	2	2	1	50.0%	11	5	45.5%	13	6	46.2%	5	4	80.0%	0	2	2.0	-7	4	14	55.9%
1/14	NYK	W 112-101	40	27	6	5	0	1	1	3	1	33.3%	13	6	46.2%	16	7	43.8%	13	12	92.3%	0	6	5.0	+11	2	33	62.2%
1/12	LAL	W 124-112	36	32	2	6	0	3	0	0	0	0.0%	19	14	73.7%	19	14	73.7%	5	4	80.0%	0	2	0.0	+4	2	39	75.5%
1/11	HOU	W 111-98	36	22	2	6	0	0	0	0	0	0.0%	13	8	61.5%	13	8	61.5%	6	6	100.0%	0	2	0.0	+13	1	29	70.3%
1/9	GSW	L 137-103	34	24	2	3	0	3	0	2	1	50.0%	17	9	52.9%	19	10	52.6%	5	3	60.0%	2	0	0.0	-22	1	23	56.6%
1/6	DAL	L 100-98	36	21	2	5	1	2	1	6	3	50.0%	12	5	41.7%	18	8	44.4%	2	2	100.0%	1	1	5.0	+2	2	18	55.6%
1/4	MIL	L 115-98	28	11	4	3	0	1	2	1	0	0.0%	10	4	40.0%	11	4	36.4%	7	3	42.9%	0	4	1.5	-22	3	6	39.1%
1/2	PHX	L 129-102	29	13	2	3	0	2	3	2	0	0.0%	6	4	66.7%	8	4	50.0%	6	5	83.3%	0	2	1.0	-12	2	14	61.1%
1/1	BOS	L 120-106	34	25	5	6	0	1	0	3	1	33.3%	13	8	61.5%	16	9	56.3%	6	6	100.0%	1	4	0.0	-13	2	31	67.1%
12/30	LAC	L 131-90	27	8	7	3	1	1	2	2	0	0.0%	6	2	33.3%	8	2	25.0%	5	4	80.0%	0	7	1.5	-19	1	11	39.2%
12/28	LAL	L 125-101	33	22	4	5	0	1	3	2	1	50.0%	15	7	46.7%	17	8	47.1%	5	5	100.0%	2	2	1.7	-14	2	22	57.3%
12/27	DAL	W 113-107	27	9	4	6	1	2	0	2	0	0.0%	8	3	37.5%	10	3	30.0%	3	3	100.0%	0	4	0.0	+8	1	17	39.8%
12/23	DET	L 136-127	41	37	3	8	0	0	1	3	0	0.0%	15	12	80.0%	18	12	66.7%	15	13	86.7%	1	2	8.0	-5	3	43	75.2%
12/21	HOU	W 125-124	40	27	4	9	1	2	1	2	1	50.0%	15	8	53.3%	17	9	52.9%	9	8	88.9%	1	3	9.0	+8	3	35	64.4%
12/20	POR	L 98-93	34	15	5	1	0	5	1	6	1	16.7%	6	4	66.7%	12	5	41.7%	5	4	80.0%	0	5	1.0	-5	0	20	52.8%
12/18	POR	L 134-133	34	33	4	3	0	2	2	4	3	75.0%	12	7	58.3%	16	10	62.5%	10	10	100.0%	0	4	1.5	+4	4	35	80.9%
12/14	MIN	L 117-103	39	17	4	3	1	1	0	1	1	100.0%	14	7	50.0%	15	8	53.3%	0	0	0.0%	0	4	0.0	-10	2	22	56.7%
12/11	DEN	L 136-105	21	11	3	1	1	1	0	1	1	100.0%	6	3	50.0%	7	4	57.1%	2	2	100.0%	0	3	0.0	-27	1	14	69.8%
12/8	IND	L 116-105	36	20	5	3	0	1	1	2	0	0.0%	14	8	57.1%	16	8	50.0%	5	4	80.0%	3	2	3.0	-14	4	17	54.9%
12/6	MIA	W 127-111	39	13	6	6	0	2	0	2	1	50.0%	9	5	55.6%	11	6	54.5%	1	0	0.0%	1	5	0.0	+21	2	20	56.8%
12/3	HOU	L 121-95	22	12	2	0	0	1	2	1	0	0.0%	11	6	54.5%	12	6	50.0%	0	0	0.0%	0	2	0.0	-6	1	6	50.0%
11/30	MEM	L 115-107	34	23	1	4	1	3	0	5	3	60.0%	12	6	50.0%	17	9	52.9%	2	2	100.0%	0	1	0.0	-9	2	25	64.3%
11/28	UTA	L 128-119	36	16	2	3	0	1	2	1	1	100.0%	9	4	44.4%	10	5	50.0%	5	5	100.0%	0	2	1.5	+7	2	15	65.6%
11/26	PHX	L 112-100	36	10	3	3	0	0	1	2	0	0.0%	9	4	44.4%	11	4	36.4%	2	2	100.0%	0	3	3.0	-16	3	7	42.1%
11/24	MIN	W 117-112	31	33	0	4	0	3	2	0	0	0.0%	16	9	56.3%	16	9	56.3%	15	15	100.0%	0	0	2.0	+0	2	39	73.0%
11/22	DEN	W 128-123	30	17	7	5	1	0	3	1	0	0.0%	8	5	62.5%	9	5	55.6%	7	7	100.0%	1	6	1.7	+4	0	29	70.4%
11/20	MEM	L 137-96	15	7	0	2	0	1	0	0	0	0.0%	3	2	66.7%	3	2	66.7%	3	3	100.0%	0	0	0.0	-22	4	7	81.0%
11/19	OKC	L 113-99	34	17	3	5	0	3	1	2	0	0.0%	10	4	40.0%	12	4	33.3%	10	9	90.0%	2	1	5.0	-12	3	20	51.8%
11/16	SAS	L 123-110	39	27	2	4	0	2	1	1	1	100.0%	14	11	78.6%	15	12	80.0%	2	2	100.0%	1	1	4.0	-23	4	28	85.0%
11/14	MIN	L 124-110	34	6	3	5	0	2	0	2	0	0.0%	8	3	37.5%	10	3	30.0%	0	0	0.0%	0	3	0.0	-11	3	6	30.0%
11/12	ATL	L 133-100	19	4	2	2	0	1	2	1	0	0.0%	5	1	20.0%	6	1	16.7%	2	2	100.0%	1	1	1.0	-31	1	2	29.1%
11/11	DEN	L 122-108	30	18	1	2	1	1	0	6	2	33.3%	9	5	55.6%	15	7	46.7%	2	2	100.0%	1	0	0.0	-19	2	15	56.7%
11/9	MIN	L 144-117	28	22	3	2	0	1	2	3	3	100.0%	8	4	50.0%	11	7	63.6%	5	5	100.0%	0	3	1.0	-19	3	21	83.3%
11/7	OKC	L 132-101	28	18	4	3	0	0	1	7	4	57.1%	6	3	50.0%	13	7	53.8%	0	0	0.0%	1	3	3.0	-21	3	16	69.2%
11/5	GSW	W 121-116	35	25	2	2	0	1	1	1	0	0.0%	19	8	42.1%	20	8	40.0%	9	9	100.0%	0	2	2.0	+1	1	17	52.2%
11/3	DEN	L 130-124	35	19	3	0	0	1	0	1	0	0.0%	16	8	50.0%	17	8	47.1%	4	3	75.0%	0	3	0.0	+11	2	12	50.6%
11/1	MIL	W 135-133	41	29	4	3	0	0	2	1	0	0.0%	18	10	55.6%	19	10	52.6%	10	9	90.0%	0	4	1.5	+4	2	28	62.0%
10/29	CHI	L 126-113	34	19	6	5	0	0	2	0	0	0.0%	10	5	50.0%	10	5	50.0%	10	9	90.0%	1	5	2.5	-21	2	26	66.0%
10/28	OKC	L 107-101	33	19	1	3	0	2	0	2	0	0.0%	12	7	58.3%	14	7	50.0%	6	5	83.3%	0	1	0.0	+0	1	22	57.1%
10/26	LAL	L 127-120	39	21	6	3	0	1	1	6	2	33.3%	16	7	43.8%	22	9	40.9%	1	1	100.0%	0	6	3.0	-4	1	18	46.8%
10/24	UTA	W 105-104	36	7	3	6	0	2	1	0	0	0.0%	9	3	33.3%	9	3	33.3%	1	1	100.0%	0	3	6.0	-15	1	14	37.1%
10/22	PHX	L 120-116	37	29	6	9	1	2	1	2	1	50.0%	15	11	73.3%	17	12	70.6%	9	4	44.4%	2	4	9.0	+9	2	44	69.2%
Regular Season Totals			31.2	18.4	2.9	4.1	0.3	1.0	1.2	1.9	0.6	32.0%	11.1	5.9	52.7%	13.1	6.5	49.7%	5.6	4.9	86.8%	0.5	2.5	3.3	-588	1.9	22.2	59.4%

DeMar DeRozan: Breaking News

DeRozan (hamstring) has been ruled out for Sunday's game against Portland. DeRozan will end the season with a third consecutive absence due to a right hamstring injury. The veteran forward will finish the 2025-26 campaign having averaged fewer than 20 points per game for the first time since 2012-2013. He will end the season with averages of 18.4 points, 4.1 assists, 2.9 rebounds and 1.0 steals in 31.2 minutes per game across 77 regular-season appearances.

DeRozan (hamstring) is out for Friday's game against the Warriors. DeRozan has been ruled out for a second straight contest while dealing with a right hamstring issue. He'll have a chance to return for Sacramento's regular-season finale against the Trail Blazers, though there's no reason to rush him back into action at this point.

DeRozan is out for Tuesday's game against the Warriors due to right hamstring soreness. It's set to be a rare absence for the star forward, who's sidelined for just the third time all year. With DeRozan out of action Tuesday, Daeqwon Plowden figures to jump into the starting lineup at small forward while veterans Malik Monk and Doug McDermott likely see an uptick in playing time.